APA (7th ed.) Citation

JD, H., 3rd, B. H., 3rd, B. F., JE, B., M, B., & FA, G. (2001). Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research Network. Cancer, 92(9), 2391. https://doi.org/10.1002/1097-0142(20011101)92:9<2391::aid-cncr1587>3.0.co;2-m

Chicago Style (17th ed.) Citation

JD, Hainsworth, Burris HA 3rd, Billings FT 3rd, Bradof JE, Baker M, and Greco FA. "Weekly Docetaxel with Either Gemcitabine or Vinorelbine as Second-line Treatment in Patients with Advanced Nonsmall Cell Lung Carcinoma: Phase II Trials of the Minnie Pearl Cancer Research Network." Cancer 92, no. 9 (2001): 2391. https://doi.org/10.1002/1097-0142(20011101)92:9<2391::aid-cncr1587>3.0.co;2-m.

MLA (9th ed.) Citation

JD, Hainsworth, et al. "Weekly Docetaxel with Either Gemcitabine or Vinorelbine as Second-line Treatment in Patients with Advanced Nonsmall Cell Lung Carcinoma: Phase II Trials of the Minnie Pearl Cancer Research Network." Cancer, vol. 92, no. 9, 2001, p. 2391, https://doi.org/10.1002/1097-0142(20011101)92:9<2391::aid-cncr1587>3.0.co;2-m.